A number sign (#) is used with this entry because adolescent nephropathic cystinosis is caused by homozygous or compound heterozygous mutation in the CTNS gene (606272), which encodes cystinosin, on chromosome 17p13.
See219800 for general information about nephropathic cystinosis and the infantile type of the disorder.
Adolescent nephropathic cystinosis manifests itself first at age 10 to 12 years with proteinuria due to glomerular damage rather than with the manifestations of tubular damage that occur first in infantile cystinosis. There is no excess amino aciduria and stature is normal. Photophobia, late development of pigmentary retinopathy, and chronic headaches are features. White cells show high cystine content in heterozygotes for this form of cystinosis, just as they do in infantile cystinosis.Spear et al. (1971) described glomerular changes in renal biopsies from a case of late-onset nephropathic cystinosis. Clinically the disorder shows a slowly progressive glomerular insufficiency rather than the prominent Fanconi syndrome, electrolyte and water disturbances, growth arrest, and rickets typical of infantile cystinosis. The patient was the only affected person in the family and the parents were not related (as one would expect if juvenile cystinosis is the genetic compound of infantile cystinosis and adult cystinosis).
Attard et al. (1999) identified a mutation in the CTNS gene (606272.0008) in a patient with late-onset juvenile nephropathic cystinosis.
Thoene et al. (1999) described 2 sibs in Taiwan with intermediate cystinosis who had linear growth and weight gain within 2 standard deviations of the mean for their ethnic group until the ages of 13 and 14 years when their plasma creatinine concentrations were 1.2 mg per deciliter and 3.3 mg per deciliter, respectively. They were found to be homozygous for a missense mutation in the CTNS gene substitution of lysine for the conserved asparagine at position 323 (N323K;606272.0016). Presumably, this mutation allowed for some residual cystine transport, accounting for the mild clinical presentation.
In 2 unrelated Spanish patients with juvenile-onset cystinosis,Macias-Vidal et al. (2009) identified compound heterozygosity for a missense mutation (S139F;606272.0018) and truncating mutations (606272.0004 and606272.0005, respectively). The S139F mutation had previously been identified in a patient with 'nonclassic' cystinosis (see219800), with onset before age 7 years but a milder course of disease than the infantile nephropathic form, byAttard et al. (1999), who suggested that the mutation might allow production of functional protein or be located in a region of cystinosin that was not functionally important.
Attard, M., Jean, G., Forestier, L., Cherqui, S., van't Hoff, W., Broyer, M., Antignac, C., Town, M.Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum. Molec. Genet. 8: 2507-2514, 1999. [PubMed:10556299,related citations] [Full Text]
Goldman, H., Scriver, C. R., Aaron, K., Delvin, E., Canlas, Z.Adolescent cystinosis: comparisons with infantile and adult forms. Pediatrics 47: 979-988, 1971. [PubMed:5141767,related citations]
Langman, C. B., Moore, E. S., Thoene, J. G., Schneider, J. A.Renal failure in a sibship with late-onset cystinosis. J. Pediat. 107: 755-756, 1985. [PubMed:4056976,related citations] [Full Text]
Macias-Vidal, J., Rodes, M., Hernandez-Perez, J. M., Vilaseca, M. A., Coll, M. J.Analysis of the CTNS gene in 32 cystinosis patients from Spain. (Letter) Clin. Genet. 76: 486-489, 2009. [PubMed:19863563,related citations] [Full Text]
McDowell, G. A., Gahl, W. A., Stephenson, L. A., Schneider, J. A., Weissenbach, J., Polymeropoulos, M. H., Town, M. M., van't Hoff, W., Farrall, M., Mathew, C. G.Linkage of the gene for cystinosis to markers on the short arm of chromosome 17. Nature Genet. 10: 246-248, 1995. [PubMed:7663525,related citations] [Full Text]
Spear, G. S., Slusser, R. J., Shulman, J. D., Alexander, F.Polykaryocytosis of the visceral glomerular epithelium in cystinosis with description of an unusual clinical variant. Johns Hopkins Med. J. 129: 83-99, 1971. [PubMed:5567604,related citations]
Thoene, J., Lemons, R., Anikster, Y., Mullet, J., Paelicke, K., Lucero, C., Gahl, W., Schneider, J., Shu, S. G., Campbell, H. T.Mutations of CTNS causing intermediate cystinosis. Molec. Genet. Metab. 67: 283-293, 1999. [PubMed:10444339,related citations] [Full Text]
Alternative titles; symbols
SNOMEDCT: 22830006; ORPHA: 213, 411634; DO: 1064;
| Location | Phenotype | Phenotype MIM number | Inheritance | Phenotype mapping key | Gene/Locus | Gene/Locus MIM number |
|---|---|---|---|---|---|---|
| 17p13.2 | Cystinosis, late-onset juvenile or adolescent nephropathic | 219900 | Autosomal recessive | 3 | CTNS | 606272 |
A number sign (#) is used with this entry because adolescent nephropathic cystinosis is caused by homozygous or compound heterozygous mutation in the CTNS gene (606272), which encodes cystinosin, on chromosome 17p13.
See 219800 for general information about nephropathic cystinosis and the infantile type of the disorder.
Adolescent nephropathic cystinosis manifests itself first at age 10 to 12 years with proteinuria due to glomerular damage rather than with the manifestations of tubular damage that occur first in infantile cystinosis. There is no excess amino aciduria and stature is normal. Photophobia, late development of pigmentary retinopathy, and chronic headaches are features. White cells show high cystine content in heterozygotes for this form of cystinosis, just as they do in infantile cystinosis. Spear et al. (1971) described glomerular changes in renal biopsies from a case of late-onset nephropathic cystinosis. Clinically the disorder shows a slowly progressive glomerular insufficiency rather than the prominent Fanconi syndrome, electrolyte and water disturbances, growth arrest, and rickets typical of infantile cystinosis. The patient was the only affected person in the family and the parents were not related (as one would expect if juvenile cystinosis is the genetic compound of infantile cystinosis and adult cystinosis).
Attard et al. (1999) identified a mutation in the CTNS gene (606272.0008) in a patient with late-onset juvenile nephropathic cystinosis.
Thoene et al. (1999) described 2 sibs in Taiwan with intermediate cystinosis who had linear growth and weight gain within 2 standard deviations of the mean for their ethnic group until the ages of 13 and 14 years when their plasma creatinine concentrations were 1.2 mg per deciliter and 3.3 mg per deciliter, respectively. They were found to be homozygous for a missense mutation in the CTNS gene substitution of lysine for the conserved asparagine at position 323 (N323K; 606272.0016). Presumably, this mutation allowed for some residual cystine transport, accounting for the mild clinical presentation.
In 2 unrelated Spanish patients with juvenile-onset cystinosis, Macias-Vidal et al. (2009) identified compound heterozygosity for a missense mutation (S139F; 606272.0018) and truncating mutations (606272.0004 and 606272.0005, respectively). The S139F mutation had previously been identified in a patient with 'nonclassic' cystinosis (see 219800), with onset before age 7 years but a milder course of disease than the infantile nephropathic form, by Attard et al. (1999), who suggested that the mutation might allow production of functional protein or be located in a region of cystinosin that was not functionally important.
Attard, M., Jean, G., Forestier, L., Cherqui, S., van't Hoff, W., Broyer, M., Antignac, C., Town, M.Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum. Molec. Genet. 8: 2507-2514, 1999. [PubMed: 10556299] [Full Text: https://doi.org/10.1093/hmg/8.13.2507]
Goldman, H., Scriver, C. R., Aaron, K., Delvin, E., Canlas, Z.Adolescent cystinosis: comparisons with infantile and adult forms. Pediatrics 47: 979-988, 1971. [PubMed: 5141767]
Langman, C. B., Moore, E. S., Thoene, J. G., Schneider, J. A.Renal failure in a sibship with late-onset cystinosis. J. Pediat. 107: 755-756, 1985. [PubMed: 4056976] [Full Text: https://doi.org/10.1016/s0022-3476(85)80410-8]
Macias-Vidal, J., Rodes, M., Hernandez-Perez, J. M., Vilaseca, M. A., Coll, M. J.Analysis of the CTNS gene in 32 cystinosis patients from Spain. (Letter) Clin. Genet. 76: 486-489, 2009. [PubMed: 19863563] [Full Text: https://doi.org/10.1111/j.1399-0004.2009.01222.x]
McDowell, G. A., Gahl, W. A., Stephenson, L. A., Schneider, J. A., Weissenbach, J., Polymeropoulos, M. H., Town, M. M., van't Hoff, W., Farrall, M., Mathew, C. G.Linkage of the gene for cystinosis to markers on the short arm of chromosome 17. Nature Genet. 10: 246-248, 1995. [PubMed: 7663525] [Full Text: https://doi.org/10.1038/ng0695-246]
Spear, G. S., Slusser, R. J., Shulman, J. D., Alexander, F.Polykaryocytosis of the visceral glomerular epithelium in cystinosis with description of an unusual clinical variant. Johns Hopkins Med. J. 129: 83-99, 1971. [PubMed: 5567604]
Thoene, J., Lemons, R., Anikster, Y., Mullet, J., Paelicke, K., Lucero, C., Gahl, W., Schneider, J., Shu, S. G., Campbell, H. T.Mutations of CTNS causing intermediate cystinosis. Molec. Genet. Metab. 67: 283-293, 1999. [PubMed: 10444339] [Full Text: https://doi.org/10.1006/mgme.1999.2876]
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM